Macleods Nevirapine 200 mg Tablets
PDF Leaflet Revision Date: 23 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of HIV-1 infection in combination with other antiretroviral agents.
Dosage (summary)
200 mg once daily for 14 days, then 200 mg twice daily.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in breastfeeding; single dose may be used during labor.
Key Drug Interactions
- CYP3A inducers
- CYP2B inducers
- Fluconazole
- Warfarin
Contraindications
- Hypersensitivity to nevirapine
- Severe hepatic dysfunction
- End-stage renal failure
Common side effects
- Rash
- Hepatitis
- Nausea
- Headache
Counselling Points
- Report any rash immediately
- Avoid hormonal contraceptives alone
- Monitor for signs of hepatitis
Serious warnings
- Severe skin reactions
- Hepatotoxicity
- Monitor liver function
Important Disclaimer
The Macleods Nevirapine 200 mg Tablets professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
